Partners With IVI To Raise Awareness-Dengue Vaccines
March 14, 2011, 1:31 p.m.
February 22, 2011
Vaccine manufacturer Sanofi Pasteur on Monday announced plans to partner with the International Vaccine Institute (IVI) "to speed the adoption of its experimental dengue fever vaccine, which is currently in late-stage development," Reuters reports (Hirschler, 2/21). "The two groups aim to raise awareness and move dengue vaccination higher on the global health agenda," according to Media Post (Irwin, 2/21). Currently, there is no cure or vaccine for dengue fever, "which is a threat to nearly half of the world's population and a public health priority in many countries of Latin America and Asia," according to Sanofi, RTTNewsreports (2/21).